SCHEMBL3540872

SCHEMBL3540872

CCCCCCCCCCCCCCCCC(O)CN(CCCC)CCCC

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 8/20 0.47
PLA2G1B P04054 3/20 0.47
PLA2G2A P14555 1/20 0.47
FFAR1 O14842 2/20 0.46
FFAR4 Q5NUL3 1/20 0.46
KDM4E B2RXH2 1/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SPHK1 Q9NYA1 1/20 0.41
PSMD14 O00487 2/20 0.41
MMP2 P08253 2/20 0.41
ATG4B Q9Y4P1 2/20 0.41
HSP90AA1 P07900 1/20 0.41
RAD52 P43351 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11611967 1.00 GPR84 (0.47) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL3531190 1.00 GPR84 (0.47) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL26039947 0.96 GPR84 (0.47) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL18789543 0.94 GPR84 (0.43) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL14833428 0.93 PLA2G1B (0.44) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL29234717 0.92 GPR84 (0.44) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL29234705 0.92 GPR84 (0.44) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL3534599 0.92 GPR84 (0.47) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL17199810 0.92 GPR84 (0.47) GPR84PLA2G1BPLA2G2AFFAR1FFAR4
SCHEMBL11697391 0.92 DNM1 (0.44) GPR84PLA2G1BPLA2G2AFFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1812401-B1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF SE (DE) 2015-06-24 EP disclosed
US-7799920-B2 Method for producing perylene-3,4-dicarboxylic acid imides BASF AKTIENGESELLSCHAFT (DE) 2010-09-21 US disclosed
US-20080114170-A1 Method For Producing Perylene-3,4-Dicarboxylic Acid Imides BASF AKTIENGESELLSCHAFT (DE) 2008-05-15 US disclosed
EP-1812401-A1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF AKTIENGESELLSCHAFT (DE) 2007-08-01 EP disclosed
WO-2006050860-A1 METHOD FOR PRODUCING PERYLENE-3,4-DICARBOXYLIC ACID IMIDES BASF AKTIENGESELLSCHAFT (DE) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080114170-A1 Method For Producing Perylene-3,4-Dicarboxylic Acid Imides CPNE4, IDH3A, RPL23A GPR84 2855/4885PLA2G1B 3619/4885PLA2G2A 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.